Effect of Hemoglobin Level on Long-Term All-Cause Mortality After Percutaneous Coronary Intervention in African-Americans

American Journal of Cardiology

Volumn 103, Issue 8, 2009, Pages 1078-1082

  Poludasu, Shyam ^a   Marmur, Jonathan D ^a   Weedon, Jeremy ^a   Khan, Waqas ^a   Cavusoglu, Erdal ^a  

^a Affiliated Faculty Global Institute of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ADULT; AFRICAN AMERICAN; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; THROMBOSIS; WORLD HEALTH ORGANIZATION;

AFRICAN AMERICANS; AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY ARTERY DISEASE; ERYTHROCYTE INDICES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 64149132651     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.12.032     Document Type: Article

References (24)

1. Reinecke H., Trey T., Wellmann J., Heidrich J., Fobker M., Wichter T., Walter M., Breithardt G., and Schaefer R.M. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24 (2003) 2142-2150
2. McKechnie R.S., Smith D., Montoye C., Kline-Rogers E., O'Donnell M.J., DeFranco A.C., Meengs W.L., McNamara R., McGinnity J.G., Patel K., et al., Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110s (2004) 271-277
3. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
4. Perry G.S., Byers T., Yip R., and Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr 122 (1992) 1417-1424
5. Beutler E., and West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106 (2005) 740-745
6. Marmur J.D., Poludasu S., Agarwal A., Vladutiu P., Feit A., Lapin R., and Cavusoglu E. Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention. J Invasive Cardiol 18 (2006) 521-526
7. Marmur J.D., Poludasu S., Agarwal A., Manjappa N., and Cavusoglu E. High-dose tirofiban administered as bolus-only during percutaneous coronary intervention. J Invasive Cardiol 20 (2008) 53-58
8. Gottlieb S.S. Dead is dead-artificial definitions are no substitute. Lancet 349 (1997) 662-663
9. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for a reassessment?. J Am Coll Cardiol 34 (1999) 618-620
10. Curb J.D., Ford C.E., Pressel S., Palmer M., Babcock C., and Hawkins C.M. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol 121 (1985) 754-766
11. Nutritional Anaemias. Report of a WHO Scientific Group. World Health Organization Technical Report Series No. 405 (1968), World Health Organisation, Geneva 9-10.
12. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Hogg R.J., Perrone R.D., Lau J., Eknoyan G., and National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
13. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106 (2002) 1893-1900
14. Bovill E.G., Terrin M.L., Stump D.C., Berke A.D., Frederick M., Collen D., Feit F., Gore J.M., Hillis L.D., and Lambrew C.T. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI), phase II trial. Ann Intern Med 115 (1991) 256-265
15. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., et al., REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
16. Lin D., Wei L., and Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80 (1993) 557-572
17. Cavusoglu E., Chopra V., Gupta A., Clark L.T., Eng C., and Marmur J.D. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 98 (2006) 580-584
18. Bunn H.F. Pathophysiology of the anemias. In: Isselbacher K.J., Braunwald E., Martin J.B., Fauci A.S., Wilson J.D., and Kasper D.L. (Eds). Harrison's Principles of Internal Medicine. 13th Ed. (1994), McGraw-Hill, New York 1720-1721
19. Dillmann E., Johnson D.G., Martin J., Mackler B., and Finch C. Catecholamine elevation in iron deficiency. Am J Physiol Regul Integr Comp Physiol 237 (1979) R297-R300
20. Takahashi M., Kurokawa S., Tsuyusaki T., and Kikawada. Studies of hyperkinetic circulatory state in chronic anemia. J Cardiol 20 (1990) 331-339
21. Nikolsky E., Mehran R., Aymong E.D., Mintz G.S., Lansky A.J., Lasic Z., Negoita M., Fahy M., Pocock S.J., Na Y., et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 1023-1027
22. Means R.T. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 13 (1995) 32-37
23. Gach O., Legrand V., Biessaux Y., Chapelle J.P., Vanbelle S., and Pierard L.A. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 99 (2007) 31-35
24. Husemann W., Fobker M., Pohlen M., Bruch C., Hausberg M., Breithardt G., and Reinecke H. Impact of haemoglobin concentration and chronic kidney disease in patients with coronary heart disease undergoing percutaneous coronary interventions. Nephrol Dial Transplant 22 (2007) 2563-2570